Triple
T903525
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | 2018–2020 Kivu Ebola epidemic in the Democratic Republic of the Congo |
E19496
|
entity |
| Predicate | treatmentUsed |
P4714
|
FINISHED |
| Object |
REGN-EB3
REGN-EB3 is a monoclonal antibody cocktail developed by Regeneron to treat Ebola virus disease, shown to significantly reduce mortality in clinical trials.
|
E106452
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a4939e889c8190ac148b3ac1a7f90b |
elicitation | completed |
| NER | batch_69a4b2b9339081909af5ab231be39bb0 |
ner | completed |
| NED1 | batch_69a7c736bb6c8190a9cad1ef536be785 |
ned_source_triple | completed |
| NED2 | batch_69a7c888cd98819082dc39739d14dc67 |
ned_description | completed |
| NEDg | batch_69a7c7a5f03c81908bd3ed9eb3710141 |
nedg | completed |
Created at: March 1, 2026, 7:39 p.m.